NSE ScannerComparison · NSE · data 2026-10-31
Laurus Labs Ltd. vs Torrent Pharmaceuticals Ltd
In plain words
Size: Torrent Pharmaceuticals Ltd is about 1.4 times the market value of Laurus Labs Ltd..
Valuation (P/E): Laurus Labs Ltd. 97.1 vs Torrent Pharmaceuticals Ltd 75.6.
Return on equity: Torrent Pharmaceuticals Ltd 27.1% vs Laurus Labs Ltd. 18.2%.
Profit growth over 3 years: Torrent Pharmaceuticals Ltd 20.2% a year vs Laurus Labs Ltd. 4% a year.
Debt to equity: Torrent Pharmaceuticals Ltd 1.79 vs Laurus Labs Ltd. 0.48.
Differences in the numbers, not a recommendation of either stock.
Side by side
| LAURUSLABS | TORNTPHARM | |
|---|---|---|
| Price | ₹2,405.5 | ₹4,613.4 |
| Market cap | ₹1,29,243 cr | ₹1,76,300 cr |
| P/E | 97.1 | 75.6 |
| P/B | 21.5 | 9.6 |
| ROE | 18.2% | 27.1% |
| ROCE | 20.5% | 13.5% |
| Debt / equity | 0.48 | 1.79 |
| Operating margin | 24.1% | 22.1% |
| Dividend yield | 0.08% | 0.82% |
| Sales growth, 3 years (yearly) | 4.1% | 12.5% |
| Profit growth, 3 years (yearly) | 4.0% | 20.2% |
| 1-year return | 149.8% | 28.0% |
| Revenue, last 12 months | ₹7,823 cr | ₹17,400 cr |
| Net profit, last 12 months | ₹1,340 cr | ₹2,124 cr |
| Latest quarter | Jun 2024 | Dec 2025 |
| Quarter net profit | ₹13 cr | ₹635 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 27.49% | 68.31% |
| Health check | Average (6/10) | Average (4.9/10) |
Common questions
Which has a higher P/E, Laurus Labs Ltd. or Torrent Pharmaceuticals Ltd?
Laurus Labs Ltd. trades at the higher P/E (97.1 against 75.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Torrent Pharmaceuticals Ltd (27.1% against 18.2%).
Which carries more debt?
Torrent Pharmaceuticals Ltd has the higher debt-to-equity ratio (1.79 against 0.48).